Subpart I - PAYMENT FOR DRUGS
- Section 447.500 - Basis and purpose
- Section 447.502 - Definitions
- Section 447.504 - Determination of average manufacturer price
- Section 447.505 - Determination of best price
- Section 447.506 - Authorized generic drugs
- Section 447.507 - Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs)
- Section 447.508 - Exclusion from best price of certain sales at a nominal price
- Section 447.509 - Medicaid drug rebates (MDR)
- Section 447.510 - Requirements for manufacturers
- Section 447.511 - Requirements for States
- Section 447.512 - Drugs: Aggregate upper limits of payment
- Section 447.514 - Upper limits for multiple source drugs
- Section 447.516 - Upper limits for drugs furnished as part of services
- Section 447.518 - State plan requirements, findings, and assurances
- Section 447.520 - Federal Financial Participation (FFP): Conditions relating to physician-administered drugs
- Section 447.522 - Optional coverage of investigational drugs and other drugs not subject to rebate